Searched over 200M research papers
10 papers analyzed
These studies suggest that NAD+ supplementation and its precursors may offer therapeutic benefits for aging, neurodegenerative diseases, metabolic disorders, and muscle insulin sensitivity, though some studies show no improvement in mitochondrial or skeletal muscle function in older adults.
20 papers analyzed
Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme present in all living cells, playing a vital role in redox reactions and serving as a cosubstrate for enzymes like sirtuins and poly(ADP-ribose) polymerases (PARPs). NAD+ levels naturally decline with age, which can lead to various age-associated pathologies, including metabolic and neurodegenerative diseases .
Aging is characterized by a systemic decrease in NAD+ levels across multiple tissues, which contributes to defects in nuclear and mitochondrial functions . This decline is linked to the dysfunction of NAD+-dependent enzymes, such as sirtuins, which are involved in metabolic regulation and circadian rhythm.
Supplementing with NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), has shown promise in restoring NAD+ levels and ameliorating age-related functional defects . These precursors can enhance oxidative metabolism, improve insulin sensitivity, and protect against metabolic abnormalities induced by high-fat diets .
Studies have demonstrated that NAD+ precursor supplementation can improve metabolic health. For instance, NMN supplementation in overweight or obese postmenopausal women with prediabetes increased muscle insulin sensitivity and insulin signaling. Similarly, NR supplementation has been shown to enhance oxidative metabolism and protect against diet-induced obesity.
NAD+ supplementation has also been explored as a strategy to prevent cognitive decline associated with aging and neurodegenerative diseases. Research indicates that increasing NAD+ levels through supplementation can potentially mitigate age-related cognitive decline, Alzheimer's disease, and other forms of dementia .
A systematic review of randomized clinical trials found that NAD+ and its precursors are generally well-tolerated, with common side effects including muscle pain, nervous disorders, fatigue, sleep disturbances, and headaches. These side effects were not deemed serious, suggesting that NAD+ supplementation is safe for most individuals.
While preclinical studies in animals have shown significant benefits of NAD+ supplementation, the results in human trials have been mixed. For example, a study on physically compromised older adults found that NAD+ precursor supplementation did not significantly improve mitochondrial or skeletal muscle function. This highlights the need for further research to understand the specific conditions under which NAD+ supplementation is most effective.
Given the promising but varied results, more controlled clinical trials are necessary to establish the efficacy and optimal dosing of NAD+ precursors in different populations and disease contexts . These studies will help clarify the therapeutic potential of NAD+ supplementation and guide its use in clinical practice.
NAD+ supplementation, particularly with precursors like NR and NMN, holds significant promise for improving metabolic health, cognitive function, and overall quality of life in aging populations. While the safety profile is generally favorable, further research is needed to confirm the clinical benefits and optimize treatment protocols. As the understanding of NAD+ biology continues to evolve, it may pave the way for effective anti-aging interventions and therapies for age-associated diseases.
Most relevant research papers on this topic